1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production

C G Larsen1, M Kristensen, K Paludan

  • 1Department of Dermatology, Marselisborg University Hospital, Aarhus, Denmark.

Insights

1,25(OH)2-D3, a vitamin D hormone, effectively inhibits Interleukin-8 (IL-8) production and gene expression in key inflammatory cells. This suggests a potential therapeutic role for vitamin D in managing inflammatory conditions.

Area of Science:

  • Immunology
  • Endocrinology
  • Dermatology

Background:

  • Interleukin-8 (IL-8) is a critical cytokine involved in inflammation, produced by various cells including keratinocytes, fibroblasts, monocytes, and endothelial cells.
  • IL-8's role in inflammation makes it a significant therapeutic target for managing inflammatory diseases.

Purpose of the Study:

  • To investigate the effect of 1,25(OH)2-cholecalciferol (1,25(OH)2-D3), an endogenous immune modulator, on Interleukin-1 (IL-1)-induced Interleukin-8 (IL-8) production.
  • To determine if 1,25(OH)2-D3 can modulate IL-8 production and gene expression in different cell types.

Main Methods:

  • Cultured keratinocytes, fibroblasts, peripheral blood monocytes (PBMC), and endothelial cells were stimulated with IL-1 alpha.
  • The effect of varying concentrations of 1,25(OH)2-D3 on IL-8 production and mRNA expression was measured.

Main Results:

  • 1,25(OH)2-D3 significantly inhibited IL-1 alpha-induced IL-8 production and mRNA expression in keratinocytes, fibroblasts, and PBMC.
  • No significant inhibition of IL-8 production was observed in endothelial cells treated with 1,25(OH)2-D3.
  • Optimal inhibitory concentrations of 1,25(OH)2-D3 ranged from 10(-10) to 10(-11) M.

Conclusions:

  • 1,25(OH)2-D3 demonstrates a regulatory role in controlling chemotactic cytokine production, specifically IL-8.
  • The findings suggest a potential therapeutic application for 1,25(OH)2-D3 in conditions characterized by excessive IL-8-mediated inflammation.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...